Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?
activated partial thromboplastin time
external quality assessment
harmonization
Journal
Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305
Informations de publication
Date de publication:
15 Jun 2021
15 Jun 2021
Historique:
received:
09
09
2020
accepted:
09
03
2021
entrez:
18
6
2021
pubmed:
19
6
2021
medline:
20
8
2021
Statut:
ppublish
Résumé
Activated partial thromboplastin time (aPTT) is determined and reported as clotting time in seconds aPTT(s), but it is presumed that reporting results as patient-to-normal clotting time ratio, aPTT(r), could minimize within-laboratory variability. The aim of study was to investigate differences in reporting aPTT results that can affect comparability of the results among Croatian laboratories and suggest further steps for its harmonization. The questionnaire on aPTT reporting practice was distributed to 83 laboratories through Survey Monkey application in March 2019 as the part of the first regular round of Croatian Centre for Quality Assessment in Laboratory Medicine proficiency testing. The survey response rate was 0.49. Majority of laboratories report aPTT results as both, seconds and ratio. Participants reported use of 23 different aPTT(s) reference intervals along with 17 different combinations of reagent/coagulometer and 25 aPTT(s) denominators of different origin for aPTT(r) calculation. Despite the same aPTT(s) results, the use of different denominators caused a dispersion of aPTT(r) results that can lead to exceeding external quality assessment performance criteria of 7%, particularly when results were compared for the same reagent group only. By applying aPTT(s) reference interval mean as denominator for calculation of aPTT(r) reference interval better concordance to harmonized one was obtained (17 In order to improve comparability of the results, laboratories are advised to use mean of aPTT(s) reference interval as denominator for aPTT(r) calculation. Type of coagulometer need to be considered when evaluating aPTT proficiency test results and its currently acceptable limit of performance evaluated accordingly.
Identifiants
pubmed: 34140831
doi: 10.11613/BM.2021.020708
pii: bm-31-2-020708
pmc: PMC8183120
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
020708Informations de copyright
Croatian Society of Medical Biochemistry and Laboratory Medicine.
Déclaration de conflit d'intérêts
Potential conflict of interest None declared.
Références
Blood Coagul Fibrinolysis. 2018 Jan;29(1):111-119
pubmed: 29232255
Biochem Med (Zagreb). 2019 Jun 15;29(2):020503
pubmed: 31223257
Semin Thromb Hemost. 2019 Feb;45(1):22-35
pubmed: 30630206
Clin Chem Lab Med. 2016 Feb;54(2):215-22
pubmed: 26351955
Arch Pathol Lab Med. 1999 Mar;123(3):199-205
pubmed: 10086507
Am J Clin Pathol. 2012 Jun;137(6):904-8
pubmed: 22586049